You are here: Industry Insights > Products Guide

News List

A Brief Overview of Research Progress in Therapeutic Targets for Chronic Cough Xiaomichong
July 15, 2024
Cough is a complex neurophysiological reflex. Cough receptors, in the form of receptors and ion channels, are located at the sensory nerve endings of the airway.
A Brief Introduction to Drug Treatment and New Drug Development for Chronic Cough Xiaomichong
July 15, 2024
Chronic cough (CC) is a common disease with a prevalence rate of up to 12%, significantly affecting the quality of life of patients.
Based on the Current Status of Drug Research and Development Targeting the Pathogenesis of Influenza (Part 2) Xiaomichong
July 12, 2024
Influenza is an acute respiratory infectious disease caused by the influenza virus.
Based on the Current Status of Drug Research and Development Targeting the Pathogenesis of Influenza (Part 1) Xiaomichong
July 12, 2024
Influenza is an acute respiratory infectious disease caused by the influenza virus.
Research Progress on the Pharmacological Effects and Mechanisms of Asiaticoside Xiaomichong
July 11, 2024
Asiaticoside is one of the main components of triterpenoid saponins extracted from Centella asiatica, with a molecular formula of C48H78O19.
Research Progress on the Pharmacological Effects and Molecular Mechanisms of Baicalein Xiaomichong
July 11, 2024
Baicalein, a flavonoid monomer compound isolated from the dried roots of the traditional Chinese medicinal herb Scutellaria baicalensis, serves as the primary pharmacological material basis of the herb.
Progress in Research on In Intrabody Delivery Strategies for Nucleic Acid Drugs (Part 2) Xiaomichong
July 10, 2024
Currently, the development of nucleic acid drugs can be divided into two major directions: chemical modification and physical modification.
Progress in Research on In Vivo Delivery Strategies for Nucleic Acid Drugs (Part 1) Xiaomichong
July 10, 2024
In recent years, nucleic acid drugs have become a research hotspot in the treatment of various incurable diseases due to their advantages such as simple design, short research and development cycle, high success rate, strong specificity, and so on.
Advances in Research on New Therapeutic Drugs for Myelodysplastic Syndromes (Part Two) Xiaomichong
July 09, 2024
In recent years, with the deepening of research into the pathogenesis of myelodysplastic syndromes (MDS), many novel drugs have emerged.
Advances in Research on New Therapeutic Drugs for Myelodysplastic Syndromes (Part one) Xiaomichong
July 09, 2024
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic malignancies characterized by defective normal hematopoiesis leading to a reduction in blood cells, with a risk of transformation into acute myeloid leukemia.